Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAL-07OLD Protocol for Ph-Negative ALL in Elderly Patients
NCT01366898Phase 4Unknown
- Sponsor
- Fundación PETHEMA
- Start
- Jun 2007
- Primary completion
- Dec 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of dexamethasone, idarubicin, cytarabine, methotrexate in acute lymphoblastic leukemia (ALL), sponsored by Fundación PETHEMA. Status: unknown.
02
Drugs
dexamethasoneidarubicincytarabinemethotrexate
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT01366898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01366898.